Roland Diggelmann resigns as CEO of Roche Diagnostics after 10 years
The Chief Executive Officer of the Swizerland-based drugmaker, Roche Diagnostics, has announced his resignation.
Ronald Diggelmann will leave the company next month following working for the firm for a decade.
The CEO, 51, joined Roche Diagnostics’ parent company, Roche, in 2008. Digglemann has worked for the diagnostics unit since 2012.
Prior to his role as CEO, Diggelmann was appoint as the Region Head of Asia Pacific for Roche Diagnostics.
Michael Heuer, the firm’s Region Head of Europe, Middle East, Africa, and Latin America, will be appoint the interim CEO in September.
“I am grateful to Roland Diggelmann for his many valuable contributions during his 10 years at Roche and I wish him all the best for the future,” stated Severin Schwan, CEO of Roche.
“I am pleased to appoint Michael Heuer as interim CEO of our Diagnostics Division.”
“Michael is a very respected leader with a wealth of experience in diagnostics.”
Heuer has worked in sales, marketing, and product develop positions in Europe and the US.
The soon-to-be CEO has also held the position of Head of Roche Near Patient Testing Business Area.
- Roche invests millions in Israel's health tech sectorTechnology & AI
- Amazon software now scrutinises patient health records, providing long-term advantagesTechnology & AI
- Roche remains the most sustainable healthcare company in the Dow Jones Sustainability IndicesMedical Devices & Pharma
- Roche acquires the outstanding shares of Foundation Medicine for $2.4bnDigital Healthcare